EGFL6 is associated with cancer cell proliferation, migration, invasion and angiogenesis52, and promotes epithelial to mesenchymal transition of the cancer stem cells53, a mechanism targeted by metformin in breast tumors54,55. This evidence concerns the gene EGFL6 and cancer.